Albireo to Present at 19th Annual BIO CEO & Investor Conference
Feb 06, 2017 13:00 pm UTC| Business
BOSTON, Feb. 06, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive...
Feb 06, 2017 13:00 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., Feb. 06, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and...
Feb 06, 2017 12:56 pm UTC| Business
Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Global Near Field Communication (NFC) Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
Feb 06, 2017 12:54 pm UTC| Business
Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Global Ophthalmic Devices Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
Feb 06, 2017 12:49 pm UTC| Business
Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Global E-Learning Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
Feb 06, 2017 12:45 pm UTC| Business
Hollywood, Feb. 06, 2017 -- Earth Science Tech, Inc.(OTC PINK: ETST) (ETST or the Company), an innovative biotech company, which focuses on cannabis-industrial hemp, cannabinoid research and development, nutraceuticals...
ICU Medical Completes the Acquisition of Hospira Infusion Systems from Pfizer
Feb 06, 2017 12:45 pm UTC| Business
SAN CLEMENTE, Calif., Feb. 06, 2017 -- ICU Medical Inc. (NASDAQ:ICUI) today announced that it has completed its acquisition of the Hospira Infusion Systems business from Pfizer Inc. (NYSE:PFE). The Hospira Infusion...